Fig. 3From: A cost-effectiveness analysis of ruxolitinib versus best alternative therapy for patients with steroid-refractory chronic graft-versus-host disease aged > 12 years in SingaporeScatter plot of probabilistic sensitivity analysis. Note: Orange triangle represents deterministic analysis results. QALY, quality-adjusted life year; SGD, Singapore dollarBack to article page